{"id":"NCT00756938","sponsor":"Organon and Co","briefTitle":"Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)","officialTitle":"A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03-01","primaryCompletion":"2012-08-14","completion":"2012-08-14","firstPosted":"2008-09-22","resultsPosted":"2014-03-03","lastUpdate":"2024-06-18"},"enrollment":101,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"losartan potassium","otherNames":["Cozaar"]}],"arms":[{"label":"Losartan potassium 0.1 to 1.4 mg/kg","type":"EXPERIMENTAL"},{"label":"Losartan potassium 0.3 to 1.4 mg/kg","type":"EXPERIMENTAL"},{"label":"Losartan potassium 0.7 to 1.4 mg/kg","type":"EXPERIMENTAL"}],"summary":"This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.","primaryOutcome":{"measure":"Mean Change From Baseline in Systolic Blood Pressure","timeFrame":"Baseline and Day 21","effectByArm":[{"arm":"Losartan Potassium 0.1 to 1.4 mg/kg","deltaMin":-7.31,"sd":12.53},{"arm":"Losartan Potassium 0.3 to 1.4 mg/kg","deltaMin":-7.65,"sd":7.49},{"arm":"Losartan Potassium 0.7 to 1.4 mg/kg","deltaMin":-6.67,"sd":7.86}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.753"}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24875194"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":34},"commonTop":["Diarrhoea","Nasopharyngitis","Respiratory tract infection","Urinary tract infection","Pyrexia"]}}